, March 17 | 12-1 p.m. ET
COVID-19 vaccine for ages 5-11 (Part 2)
At the end of this presentation, participants will be able to:
Summarize the new recommended vaccine intervals for those previously infected.
Discuss the different vaccines for children and youth, and be able to discuss pros and cons for individual patients.
Appreciate the newer concerns that are specific to COVID-19 vaccines for children.
Apply a clinical encounter framework health care providers can use to guide their vaccine discussion and increase vaccine confidence.
Cora Constantinescu, MD
University of Calgary
Alberta Children's Hospital
Marina Salvadori, MD
Montreal Children's Hospital
Public Health Agency of Canada